Regulation of u-PA gene expression in human prostate cancer

International Journal of Cancer

Volumn 94, Issue 3, 2001, Pages 390-395

  Evans, Christopher P ^a   Stapp, Eschelle C ^a   Dall'Era, Marc A ^a   Juarez, Jose ^a   Yang, Joy C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Androgen; Prostate cancer; Signal transduction; Transcriptional regulation; Urokinase

Indexed keywords

COMPLEMENTARY DNA; MIBOLERONE; MITOGEN ACTIVATED PROTEIN KINASE; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CASTRATION; CONTROLLED STUDY; GENE CONTROL; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; REGULATORY MECHANISM; REPORTER GENE; SIGNAL TRANSDUCTION;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; CHLORAMPHENICOL O-ACETYLTRANSFERASE; COLORING AGENTS; DOWN-REGULATION; FLUTAMIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MUTATION; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0035501654     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1469     Document Type: Article

References (53)

1. Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade
2. A soluble, ligand binding mutant of the human urokinase plasminogen activator receptor
3. Antibodies to plasminogen activator inhibit human tumor metastasis
4. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: An important new class of selective synthetic urokinase inhibitor
5. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis
6. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells
7. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line
8. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro
9. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder
10. Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: Comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen
11. Tissue plasminogen activator activity in prostatic cancer
12. Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues
13. Plasminogen activators in human prostate cancer cell lines and tumors: Correlation with the aggressive phenotype
14. Urokinase-type plasminogen activator expression in human prostate carcinomas
15. Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors
16. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo
17. Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats
18. Increased activity of plasminogen activators during involution of the rat ventral prostate
19. Isolation of 3 S androgen receptors from salt-resistant fractions and nuclear matrices of prostatic nuclei after mild trypsin digestion
20. The relationship between androgen receptors and the hormonally controlled responses of rat ventral prostate
21. Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines
22. Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines
23. Diversity and modulation of plasminogen activator activity in human prostate carcinoma cell lines
24. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells
25. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity
26. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer
27. Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells
28. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line
29. Stimulation of urokinase expression by TNF-alpha requires the activation of binding sites for the AP-1 and PEA3 transcription factors
30. Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene
31. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor
32. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells
33. An upstream enhancer and a negative element in the 5′ flanking region of the human urokinase plasminogen activator gene
34. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP
35. Steroid receptor family: Structure and functions
36. The constitution of a progesterone response element
37. Structural determinants of a glucocorticoid receptor recognition element
38. A consensus DNA-binding site for the androgen receptor
39. Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors
40. Modulation of hormone sensitivity in PC3 cells by transfection of a normal human androgen receptor
41. Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid
42. Regulation of urokinase production by androgens in human prostate cancer cells: Effect on tumor growth and metastases in vivo
43. Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA
44. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor
45. Repression of cAMP-induced expression of the mouse P450 17 alpha-hydroxylase/C17-20 lyase gene (Cyp17) by androgens
46. Transcriptional repression of the alpha-subunit gene by androgen receptor occurs independently of DNA binding but requires the DNA-binding and ligand-binding domains of the receptor
47. Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element
48. Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression
49. Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter
50. Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor
51. CREB-binding protein in androgen receptor-mediated signaling
52. Mutual transcriptional interference between RelA and androgen receptor
53. Transcriptional repression of the glycoprotein hormone alpha subunit gene by androgen may involve direct binding of androgen receptor to the proximal promoter